The SUSTAIN-6 trial for semaglutide (3,297 patients, median 2.1 years), LEADER trial for liraglutide (9,340 patients, median 3.8 years), and REWIND trial for dulaglutide (9,901 patients, median 5.4 years) all included comprehensive adverse event monitoring
It occurs naturally in human plasma
The Scoop on this incredible peptide CJC-1295 Ipamorelin is a powerful peptide that increases Insulin-like Growth Factor 1 (IGF-1) levels while having minimal effect on cortisol and prolactin
TB-500, a synthetic fragment derived from thymosin beta-4, interacts with actin-associated cellular machinery that regulates cytoskeletal structure and cell migration
You're getting the proven medications that deliver 15-20% average weight loss, at better pricing than brand names
Current clinical evidence The longest published retatrutide data extends to 48 weeks